Qatar Genome Programme

The Qatar Genome Programme aims to sequence the genomes of 350,000 inhabitants of Qatar.[1] Supported by the Sidra Medical and Research Center, the program is managed by Qatar Genome Committee and wants to eventually offer personalized healthcare in Qatar to its population with advances in genomics.[2] The Qatar Genome Programme published its first genome-wide association study with 45 clinically relevant traits in 2021 [3]

Apart from the Qatar Genome Programme, a number of other genome-scale studies have emerged from Qatar, including ones looking at the pharmacogenetic map[4] of Qatar from genome and exome sequences available in public domain. The availability of population-scale genomes from Qatar has also enabled the evaluation of Incidental genetic findings[5] which provides an estimate of the pathogenicity and frequency of such variants in the population, thereby forming the basis of genomic medicine in Qatar. Genetic epidemiological studies by integrating genomic data and variant annotations are also underway for autoinflammatory diseases[6]

The allele frequencies of population-scale genomes are also available[7]

See also

References

  1. ^ "WuXi NextCODE join Qatar Genome Project to power precision medicine development". Front Line Genomics. Archived from the original on 2017-04-14. Retrieved 2016-09-20.
  2. ^ "Qatar Biobank for Medical Research". www.qatarbiobank.org.qa. Archived from the original on 2020-03-29. Retrieved 2020-03-29.
  3. ^ Albagha, Thareja; Suhre, Al-Sarraj (2021). "Whole genome sequencing in the Middle Eastern Qatari population identifies genetic associations with 45 clinically relevant traits". Nature Communications. 12 (1): 1250. Bibcode:2021NatCo..12.1250T. doi:10.1038/s41467-021-21381-3. PMC 7902658. PMID 33623009.
  4. ^ Sivadas, Ambily; Scaria, Vinod (2018). "Pharmacogenomic survey of Qatari populations using whole-genome and exome sequences". The Pharmacogenomics Journal. 18 (4): 590–600. doi:10.1038/s41397-018-0022-8. PMID 29720721. S2CID 24137943.
  5. ^ Jain, Abhinav; Gandhi, Shrey; Koshy, Remya; Scaria, Vinod (August 2018). "Incidental and clinically actionable genetic variants in 1005 whole exomes and genomes from Qatar". Molecular Genetics and Genomics. 293 (4): 919–929. doi:10.1007/s00438-018-1431-8. ISSN 1617-4623. PMID 29557500. S2CID 3945453.
  6. ^ Sharma, Parul; Jain, Abhinav; Scaria, Vinod (2021). "Genetic landscape of rare autoinflammatory disease variants in Qatar and Middle Eastern populations through the integration of whole-genome and exome datasets". Frontiers in Genetics. 12 631340. doi:10.3389/fgene.2021.631340. ISSN 1664-8021. PMC 8155677. PMID 34054914.
  7. ^ Koshy, Remya; Ranawat, Anop; Scaria, Vinod (October 2017). "al mena: a comprehensive resource of human genetic variants integrating genomes and exomes from Arab, Middle Eastern and North African populations". Journal of Human Genetics. 62 (10): 889–894. doi:10.1038/jhg.2017.67. ISSN 1435-232X. PMID 28638141. S2CID 36515834.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.